These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 39000515)
1. Toxic Advanced Glycation End-Products Inhibit Axonal Elongation Mediated by β-Tubulin Aggregation in Mice Optic Nerves. Ooi H; Furukawa A; Takeuchi M; Koriyama Y Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000515 [TBL] [Abstract][Full Text] [Related]
2. The Effect of Glyceraldehyde-Derived Advanced Glycation End Products on β-Tubulin-Inhibited Neurite Outgrowth in SH-SY5Y Human Neuroblastoma Cells. Nasu R; Furukawa A; Suzuki K; Takeuchi M; Koriyama Y Nutrients; 2020 Sep; 12(10):. PubMed ID: 32992566 [TBL] [Abstract][Full Text] [Related]
3. Pyridoxamine and Aminoguanidine Attenuate the Abnormal Aggregation of β-Tubulin and Suppression of Neurite Outgrowth by Glyceraldehyde-Derived Toxic Advanced Glycation End-Products. Ooi H; Nasu R; Furukawa A; Takeuchi M; Koriyama Y Front Pharmacol; 2022; 13():921611. PubMed ID: 35721214 [TBL] [Abstract][Full Text] [Related]
4. Toxic Advanced Glycation End-Products-Dependent Alzheimer's Disease- Like Alternation in the Microtubule System. Ooi H; Koriyama Y Curr Alzheimer Res; 2023; 20(10):677-681. PubMed ID: 38357957 [TBL] [Abstract][Full Text] [Related]
5. Intracellular Toxic Advanced Glycation End-Products in 1.4E7 Cell Line Induce Death with Reduction of Microtubule-Associated Protein 1 Light Chain 3 and p62. Takata T; Sakasai-Sakai A; Takeuchi M Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057513 [TBL] [Abstract][Full Text] [Related]
6. Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease. Sato T; Shimogaito N; Wu X; Kikuchi S; Yamagishi S; Takeuchi M Am J Alzheimers Dis Other Demen; 2006; 21(3):197-208. PubMed ID: 16869341 [TBL] [Abstract][Full Text] [Related]
7. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872 [TBL] [Abstract][Full Text] [Related]
8. Structures of Toxic Advanced Glycation End-Products Derived from Glyceraldehyde, A Sugar Metabolite. Sakai-Sakasai A; Takeda K; Suzuki H; Takeuchi M Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397439 [TBL] [Abstract][Full Text] [Related]
9. Axonal protection by 17β-estradiol through thioredoxin-1 in tumor necrosis factor-induced optic neuropathy. Kitaoka Y; Munemasa Y; Hayashi Y; Kuribayashi J; Koseki N; Kojima K; Kumai T; Ueno S Endocrinology; 2011 Jul; 152(7):2775-85. PubMed ID: 21586560 [TBL] [Abstract][Full Text] [Related]
10. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Fitzgerald M; Bartlett CA; Evill L; Rodger J; Harvey AR; Dunlop SA Exp Neurol; 2009 Mar; 216(1):219-30. PubMed ID: 19118550 [TBL] [Abstract][Full Text] [Related]
11. Intracellular Toxic Advanced Glycation End-Products Promote the Production of Reactive Oxygen Species in HepG2 Cells. Sakasai-Sakai A; Takata T; Takeuchi M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660150 [TBL] [Abstract][Full Text] [Related]
12. Degeneration of retinal ganglion cells in diabetic dogs and mice: relationship to glycemic control and retinal capillary degeneration. Howell SJ; Mekhail MN; Azem R; Ward NL; Kern TS Mol Vis; 2013; 19():1413-21. PubMed ID: 23825921 [TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products Modulate Amyloidogenic APP Processing and Tau Phosphorylation: A Mechanistic Link between Glycation and the Development of Alzheimer's Disease. Batkulwar K; Godbole R; Banarjee R; Kassaar O; Williams RJ; Kulkarni MJ ACS Chem Neurosci; 2018 May; 9(5):988-1000. PubMed ID: 29384651 [TBL] [Abstract][Full Text] [Related]
14. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease. Takeuchi M; Yamagishi S Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848 [TBL] [Abstract][Full Text] [Related]
15. Role of advanced glycation end products in diabetic neuropathy. Sugimoto K; Yasujima M; Yagihashi S Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845 [TBL] [Abstract][Full Text] [Related]
16. The Association between Accumulation of Toxic Advanced Glycation End-Products and Cytotoxic Effect in MC3T3-E1 Cells. Sakasai-Sakai A; Takata T; Takeuchi M Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267965 [TBL] [Abstract][Full Text] [Related]